These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1751810)

  • 1. Vitamin E supplements fail to protect mice from acute MPTP neurotoxicity.
    Gong L; Daigneault EA; Acuff RV; Kostrzewa RM
    Neuroreport; 1991 Sep; 2(9):544-6. PubMed ID: 1751810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with antioxidants does not prevent loss of dopamine in the striatum of MPTP-treated common marmosets: preliminary observations.
    Mihatsch W; Russ H; Gerlach M; Riederer P; Przuntek H
    J Neural Transm Park Dis Dement Sect; 1991; 3(1):73-8. PubMed ID: 1905937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of MPTP and vitamin E treatments on immune function in mice.
    Chi DS; Gong L; Daigneault EA; Kostrzewa RM
    Int J Immunopharmacol; 1992 Jul; 14(5):739-46. PubMed ID: 1512070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions.
    Fornai F; Alessandrì MG; Torracca MT; Bassi L; Corsini GU
    J Pharmacol Exp Ther; 1997 Oct; 283(1):100-7. PubMed ID: 9336313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulatory effects of testosterone on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.
    Dluzen D; Jain R; Liu B
    J Neurochem; 1994 Jan; 62(1):94-101. PubMed ID: 8263548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of extracellular concentration of dopamine and its metabolites in mice striatum by a microdialysis technique at intraperitoneal administration of MPTP].
    Averkin RG; Korshunov VA; Shchegolevskiĭ NV; Mats VN; Markevich VA; Grigor'ian GA; Bazian AS
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2010; 60(1):109-19. PubMed ID: 20352690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary restriction does not protect the nigrostriatal dopaminergic pathway of older animals from low-dose MPTP-induced neurotoxicity.
    Morgan WW; Richardson AG; Nelson JF
    J Gerontol A Biol Sci Med Sci; 2003 May; 58(5):B394-9. PubMed ID: 12730246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
    Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T
    J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism.
    Anderson DW; Bradbury KA; Schneider JS
    Eur J Neurosci; 2008 Aug; 28(3):610-7. PubMed ID: 18702732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunity of fetal mice to prenatal administration of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Melamed E; Rosenthal J; Youdim MB
    J Neurochem; 1990 Oct; 55(4):1427-31. PubMed ID: 2398363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity by the novel selective dopamine D3-receptor partial agonist FAUC 329 predominantly in the nucleus accumbens of mice.
    Boeckler F; Leng A; Mura A; Bettinetti L; Feldon J; Gmeiner P; Ferger B
    Biochem Pharmacol; 2003 Sep; 66(6):1025-32. PubMed ID: 12963489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic administration of antioxidants does not protect mice against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP).
    Martinovits G; Melamed E; Cohen O; Rosenthal J; Uzzan A
    Neurosci Lett; 1986 Aug; 69(2):192-7. PubMed ID: 3489911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice.
    Beal MF; Matthews RT; Tieleman A; Shults CW
    Brain Res; 1998 Feb; 783(1):109-14. PubMed ID: 9479058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LIGA 20 increases striatal dopamine levels in aged MPTP-treated mice refractory to GM1 ganglioside treatment.
    Schneider JS; DiStefano L
    Neuroreport; 1993 Nov; 5(2):103-4. PubMed ID: 8110995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of striatal dopamine by the N-oxide of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Lau YS; Fung YK; Trobough KL; Cashman JR; Wilson JA
    Neurotoxicology; 1991; 12(2):189-99. PubMed ID: 1956580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (+)MK-801 does not prevent MPTP-induced loss of nigral neurons in mice.
    Chan P; Di Monte DA; Langston JW; Janson AM
    J Pharmacol Exp Ther; 1997 Jan; 280(1):439-46. PubMed ID: 8996226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
    Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
    Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel sites of action for deprenyl in MPTP-parkinsonism: metabolite-mediated protection against striatal neurotoxicity and suppression of MPTP-induced increase of dopamine turnover in C57BL mice.
    Sziráki I; Kardos V; Patthy M; Gaál J; Arányi P; Kollár E; Tömösközi Z; Király I
    Prog Brain Res; 1995; 106():155-71. PubMed ID: 8584651
    [No Abstract]   [Full Text] [Related]  

  • 19. MPTP-induced model of Parkinson's disease in cytochrome P450 2E1 knockout mice.
    Viaggi C; Vaglini F; Pardini C; Caramelli A; Corsini GU
    Neuropharmacology; 2009 Jun; 56(8):1075-81. PubMed ID: 19298832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selenium partially reverses the depletion of striatal dopamine and its metabolites in MPTP-treated C57BL mice.
    Khan HA
    Neurochem Int; 2010 Nov; 57(5):489-91. PubMed ID: 20619308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.